课题基金 / 基金详情

IMPROVE - Investigating Medication re-Purposing to Reduce risk of OVarian cancer and Extend survival

IMPROVE - Investigating Medication re-Purposing to Reduce risk of OVarian cancer and Extend survival
改进 - 研究重新调整药物用途以降低卵巢癌风险并延长生存期
批准号：
nhmrc : GNT1121151
负责人：
A/Pr Michael Coory
金额：
$43.02万
依托单位：
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2017
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2017-01-01 至 --
来源：
https://researchdata.edu.au/improve-investigating-medication-extend-survival/1347187
关键词：
IMPROVEInvestigatingMedicationrePurposing

项目摘要

项目成果

A/Pr Michael Coory的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer is the 6th most common cause of cancer death in women and the proportion of women who die from their disease has not improved substantially over time. This large-scale study will use de-identified data from the Pharmaceutical Benefits Scheme, the Australian Cancer Database and the National Death Index to investigate whether medications commonly used for other conditions can help decrease the risk of ovarian cancer developing or improve survival from ovarian cancer after diagnosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving the evaluation of new cancer therapies to expedite patient access
  • 批准号：
    nhmrc : 1128332
  • 项目类别：
    Project Grants
  • 资助金额：
    $28.12万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Michael Coory
  • 依托单位：
    The University of Adelaide
IMPROVE - Investigating Medication re-Purposing to Reduce risk of OVarian cancer and Extend survival
Improving the evaluation of new cancer therapies to expedite patient access
  • 批准号：
    nhmrc : GNT1128332
  • 项目类别：
    Project Grants
  • 资助金额：
    $41.29万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Michael Coory
  • 依托单位：
    Flinders University
The best service at the best time: Improving the implementation of research for children with cerebral palsy.
  • 批准号：
    nhmrc : 1055278
  • 项目类别：
    Partnerships
  • 资助金额：
    $59.55万
  • 财政年份：
    2012
  • 负责人：
    A/Pr Michael Coory
  • 依托单位：
    Australian Catholic University
海外基金